Ser243

Site Information
DDVPLsLsPskRACA SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 3214968

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 19 , 20 , 21 , 22 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 )
Disease tissue studied:	breast cancer ( 8 , 13 ) , breast ductal carcinoma ( 13 ) , HER2 positive breast cancer ( 5 ) , luminal A breast cancer ( 5 ) , luminal B breast cancer ( 5 ) , breast cancer, surrounding tissue ( 5 ) , breast cancer, triple negative ( 5 , 13 ) , cervical cancer ( 31 ) , cervical adenocarcinoma ( 31 ) , leukemia ( 24 ) , acute myelogenous leukemia ( 24 ) , acute erythroid leukemias, including erythroleukemia (M6a) and very rare pure erythroid leukemia (M6b) ( 20 ) , acute megakaryoblastic leukemia (M7) ( 20 ) , acute monoblastic leukemia (M5a) or acute monocytic leukemia (M5b) ( 20 ) , acute myeloblastic leukemia, with granulocytic maturation (M2) ( 20 ) , acute myeloblastic leukemia, without maturation (M1) ( 20 ) , lung cancer ( 11 , 15 , 21 , 27 ) , non-small cell lung cancer ( 21 ) , non-small cell lung adenocarcinoma ( 11 , 15 ) , lymphoma ( 14 ) , B cell lymphoma ( 20 ) , Burkitt's lymphoma ( 14 ) , non-Hodgkin's lymphoma ( 20 ) , follicular lymphoma ( 14 ) , mantle cell lymphoma ( 14 ) , neuroblastoma ( 1 ) , ovarian cancer ( 13 ) , multiple myeloma ( 20 ) , melanoma skin cancer ( 10 )
Relevant cell line - cell type - tissue:	293 (epithelial) [AT1 (human), transfection, AT1R stable transfected HEK293] ( 28 ) , 293E (epithelial) ( 25 ) , A498 (renal) ( 30 ) , A549 (pulmonary) [CD38 (human), transfection, Lentiviral particles containing CD38 vector were transfected] ( 3 ) , A549 (pulmonary) ( 3 , 16 ) , AML-193 (monocyte) ( 20 ) , BJAB (B lymphocyte) ( 14 ) , breast ( 5 , 13 ) , BT-474 (breast cell) ( 8 ) , Calu 6 (pulmonary) ( 21 ) , CL1-0 (pulmonary) ( 27 ) , CL1-1 (pulmonary) ( 27 ) , CL1-2 (pulmonary) ( 27 ) , CL1-5 (pulmonary) ( 27 ) , CLB-Bar ( 1 ) , CMK (megakaryoblast) ( 20 ) , CTS (myeloid) ( 20 ) , DOHH2 ('B lymphocyte, precursor') ( 20 ) , FL-18 (B lymphocyte) ( 14 ) , FL-318 (B lymphocyte) ( 14 ) , Flp-In T-Rex-293 (epithelial) [PRKD1 (human), genetic knockin] ( 22 ) , Flp-In T-Rex-293 (epithelial) ( 22 ) , GM00130 (B lymphocyte) ( 29 ) , H2009 (pulmonary) ( 21 ) , H2077 (pulmonary) ( 21 ) , H2887 (pulmonary) ( 21 ) , H322M (pulmonary) ( 21 ) , HCC1359 (pulmonary) ( 21 ) , HCC2279 (pulmonary) ( 21 ) , HCC4006 (pulmonary) ( 21 ) , HEK293T (epithelial) ( 9 ) , HEL (erythroid) ( 20 ) , HeLa (cervical) [OGT (rat), transfection] ( 32 ) , HeLa (cervical) ( 4 , 12 , 19 , 32 , 33 , 35 , 37 , 38 , 39 , 40 ) , HeLa S3 (cervical) ( 31 ) , HUES-7 ('stem, embryonic') ( 34 ) , HUES-9 ('stem, embryonic') ( 26 ) , JEKO-1 (B lymphocyte) ( 14 ) , Jurkat (T lymphocyte) ( 17 , 36 ) , K562 (erythroid) ( 19 , 33 ) , Kasumi-1 (myeloid) ( 20 ) , KG-1 (myeloid) ( 20 , 24 ) , lung ( 15 ) , MCF-7 (breast cell) ( 7 , 8 ) , MV4-11 (macrophage) ( 20 ) , NCEB-1 (B lymphocyte) ( 14 ) , NCI-H1395 (pulmonary) ( 21 ) , NCI-H1568 (pulmonary) ( 21 ) , NCI-H157 (pulmonary) ( 21 ) , NCI-H1648 (pulmonary) ( 21 ) , NCI-H1666 (pulmonary) ( 21 ) , NCI-H2030 (pulmonary) ( 21 ) , NCI-H2172 (pulmonary) ( 21 ) , NCI-H520 (squamous) ( 21 ) , NCI-H647 (pulmonary) ( 21 ) , OCI-ly1 (B lymphocyte) ( 14 ) , OPM-2 (plasma cell) ( 20 ) , ovary ( 13 ) , P31/FUJ (erythroid) ( 20 ) , PC9 (pulmonary) ( 11 , 21 ) , Raji (B lymphocyte) ( 14 ) , RAMOS (B lymphocyte) ( 14 ) , REC-1 (B lymphocyte) ( 14 ) , RL ('B lymphocyte, precursor') ( 20 ) , RPMI-8266 (plasma cell) ( 20 ) , SU-DHL-4 (B lymphocyte) ( 14 ) , SU-DHL-6 (B lymphocyte) ( 20 ) , U266 (plasma cell) ( 20 ) , UPN-1 (B lymphocyte) ( 14 ) , Vero E6-S ('epithelial, kidney') ( 2 ) , WM239A (melanocyte) ( 10 )

Upstream Regulation
Regulatory protein:	OGT (human) ( 32 )
Treatments:	metastatic potential ( 27 ) , nocodazole ( 31 )

References
1	Borenäs M, et al. (2024) ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proc Natl Acad Sci U S A 121, e2315242121 38154064 Curated Info
2	Bouhaddou M, et al. (2020) The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell 182 32645325 Curated Info
3	Wang W, et al. (2018) Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition. Mol Cell Proteomics 29980616 Curated Info
4	Huang H, et al. (2016) Simultaneous Enrichment of Cysteine-containing Peptides and Phosphopeptides Using a Cysteine-specific Phosphonate Adaptable Tag (CysPAT) in Combination with titanium dioxide (TiO2) Chromatography. Mol Cell Proteomics 15, 3282-3296 27281782 Curated Info
5	Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62 27251275 Curated Info
6	Boeing S, et al. (2016) Multiomic Analysis of the UV-Induced DNA Damage Response. Cell Rep 15, 1597-1610 27184836 Curated Info
7	Sacco F, et al. (2016) Deep Proteomics of Breast Cancer Cells Reveals that Metformin Rewires Signaling Networks Away from a Pro-growth State. Cell Syst 2, 159-71 27135362 Curated Info
8	Carrier M, et al. (2016) Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines. PLoS One 11, e0157290 27362937 Curated Info
9	Franchin C, et al. (2015) Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells. Biochim Biophys Acta 1854, 609-23 25278378 Curated Info
10	Stuart SA, et al. (2015) A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells. Mol Cell Proteomics 14, 1599-615 25850435 Curated Info
11	Tsai CF, et al. (2015) Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics. Nat Commun 6, 6622 25814448 Curated Info
12	Sharma K, et al. (2014) Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 8, 1583-94 25159151 Curated Info
13	Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704 24719451 Curated Info
14	Rolland D, et al. (2014) Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 184, 1331-42 24667141 Curated Info
15	Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96 23911959 Curated Info
16	Kim JY, et al. (2013) Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells. Proc Natl Acad Sci U S A 110, 12414-9 23836654 Curated Info
17	Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7 23749302 Curated Info
18	Shiromizu T, et al. (2013) Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 12, 2414-21 23312004 Curated Info
19	Zhou H, et al. (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12, 260-71 23186163 Curated Info
20	Casado P, et al. (2013) Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors. Genome Biol 14, R37 23628362 Curated Info
21	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info
22	Franz-Wachtel M, et al. (2012) Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells. Mol Cell Proteomics 11, 160-70 22496350 Curated Info
23	Beli P, et al. (2012) Proteomic Investigations Reveal a Role for RNA Processing Factor THRAP3 in the DNA Damage Response. Mol Cell 46, 212-25 22424773 Curated Info
24	Weber C, Schreiber TB, Daub H (2012) Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. J Proteomics 75, 1343-56 22115753 Curated Info
25	Hsu PP, et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-22 21659604 Curated Info
26	Rigbolt KT, et al. (2011) System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 4, rs3 21406692 Curated Info
27	Wang YT, et al. (2010) An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J Proteome Res 9, 5582-97 20815410 Curated Info
28	Christensen GL, et al. (2010) Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol Cell Proteomics 9, 1540-53 20363803 Curated Info
29	Bennetzen MV, et al. (2010) Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics 9, 1314-23 20164059 Curated Info
30	Schreiber TB, et al. (2010) An integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling. Mol Cell Proteomics 9, 1047-62 20071362 Curated Info
31	Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3 20068231 Curated Info
32	Wang Z, et al. (2010) Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal 3, ra2 20068230 Curated Info
33	Pan C, Olsen JV, Daub H, Mann M (2009) Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics 8, 2796-808 19651622 Curated Info
34	Van Hoof D, et al. (2009) Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 5, 214-26 19664995 Curated Info
35	Chen RQ, et al. (2009) CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 69, 2663-8 19276368 Curated Info
36	Mayya V, et al. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2, ra46 19690332 Curated Info
37	Dephoure N, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105, 10762-7 18669648 Curated Info
38	Ruse CI, et al. (2008) Motif-specific sampling of phosphoproteomes. J Proteome Res 7, 2140-50 18452278 Curated Info
39	Cantin GT, et al. (2008) Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J Proteome Res 7, 1346-51 18220336 Curated Info
40	Yu LR, et al. (2007) Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J Proteome Res 6, 4150-62 17924679 Curated Info